{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:40Z","timestamp":1787698180435,"version":"build-2784847793"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01861-w","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:35:44Z","timestamp":1757435744000},"page":"3957-3970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluphenazine, an antipsychotic compound, ameliorates Alzheimer\u2019s disease by clearing amyloid beta accumulation in C. elegans"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-4781","authenticated-orcid":false,"given":"Mayur Nimbadas","family":"Devare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Kaeberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"6","key":"1861_CR1","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1021\/acsomega.3c07046","volume":"9","author":"S Maniam","year":"2024","unstructured":"Maniam S, Maniam S. Screening techniques for drug discovery in Alzheimer\u2019s disease. ACS Omega. 2024;9(6):6059\u201373.","journal-title":"ACS Omega"},{"issue":"3","key":"1861_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/med.21773","volume":"41","author":"A Vaiserman","year":"2021","unstructured":"Vaiserman A, et al. Repurposing drugs to fight aging: the difficult path from bench to bedside. Med Res Rev. 2021;41(3):1676\u2013700.","journal-title":"Med Res Rev"},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"172784","DOI":"10.1016\/j.ejphar.2019.172784","volume":"866","author":"M Antoszczak","year":"2020","unstructured":"Antoszczak M, et al. Old wine in new bottles: drug repurposing in oncology. Eur J Pharmacol. 2020;866:172784.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1861_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A, Ekavali M. A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195\u2013203.","journal-title":"Pharmacol Rep"},{"key":"1861_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","volume":"65","author":"VJ De-Paula","year":"2012","unstructured":"De-Paula VJ, et al. Alzheimer\u2019s disease. Subcell Biochem. 2012;65:329\u201352.","journal-title":"Subcell Biochem"},{"issue":"2","key":"1861_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ddtec.2005.05.022","volume":"2","author":"A Barberis","year":"2005","unstructured":"Barberis A, et al. Yeast as a screening tool. Drug Discov Today Technol. 2005;2(2):187\u201392.","journal-title":"Drug Discov Today Technol"},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13065-015-0143-y","volume":"9","author":"X Chen","year":"2015","unstructured":"Chen X, et al. Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem Cent J. 2015;9:65.","journal-title":"Chem Cent J"},{"key":"1861_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1750-1326-7-57","volume":"7","author":"G McColl","year":"2012","unstructured":"McColl G, et al. Utility of an improved model of amyloid-beta (Abeta(1)(-)(4)(2)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer\u2019s disease. Mol Neurodegener. 2012;7:57.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1861_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci. 2019;22(3):401\u201312.","journal-title":"Nat Neurosci"},{"issue":"2","key":"1861_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2014.10.016","volume":"36","author":"WM Hassan","year":"2015","unstructured":"Hassan WM, et al. Identifying Abeta-specific pathogenic mechanisms using a nematode model of Alzheimer\u2019s disease. Neurobiol Aging. 2015;36(2):857\u201366.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1861_CR11","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.ddtec.2012.02.002","volume":"10","author":"AL Lublin","year":"2013","unstructured":"Lublin AL, Link CD. Alzheimer\u2019s disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for beta-amyloid peptide-induced toxicity. Drug Discov Today Technol. 2013;10(1):e115\u20139.","journal-title":"Drug Discov Today Technol"},{"issue":"8","key":"1861_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1534\/g3.112.003533","volume":"2","author":"JA Hardaway","year":"2012","unstructured":"Hardaway JA, et al. Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis. G3 Genes|Genomes|Genetics. 2012;2(8):961\u201375.","journal-title":"G3 Genes|Genomes|Genetics"},{"issue":"3\u20134","key":"1861_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ceca.2012.03.005","volume":"52","author":"JW Barclay","year":"2012","unstructured":"Barclay JW, Morgan A, Burgoyne RD. Neurotransmitter release mechanisms studied in Caenorhabditis elegans. Cell Calcium. 2012;52(3\u20134):289\u201395.","journal-title":"Cell Calcium"},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"101556","DOI":"10.1016\/j.arr.2021.101556","volume":"75","author":"E Aaldijk","year":"2022","unstructured":"Aaldijk E, Vermeiren Y. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer\u2019s disease: a narrative review. Ageing Res Rev. 2022;75:101556.","journal-title":"Ageing Res Rev"},{"issue":"20","key":"1861_CR15","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(20):3589\u201394.","journal-title":"J Cell Sci"},{"key":"1861_CR16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/NDT.S75717","volume":"11","author":"Z Cai","year":"2015","unstructured":"Cai Z, et al. Activation of mTOR: a culprit of Alzheimer\u2019s disease? Neuropsychiatr Dis Treat. 2015;11:1015\u201330.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1861_CR17","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17196.1","author":"D Papadopoli","year":"2019","unstructured":"Papadopoli D, et al. mTOR as a central regulator of lifespan and aging. F1000Res. 2019. https:\/\/doi.org\/10.12688\/f1000research.17196.1.","journal-title":"F1000Res"},{"issue":"2","key":"1861_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","volume":"64","author":"T Weichhart","year":"2018","unstructured":"Weichhart T. mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology. 2018;64(2):127\u201334.","journal-title":"Gerontology"},{"key":"1861_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102278","author":"S Huang","year":"2020","unstructured":"Huang S. mTOR signaling in metabolism and cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102278.","journal-title":"Cells"},{"key":"1861_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073157","author":"W Fu","year":"2023","unstructured":"Fu W, Wu G. Targeting mTOR for anti-aging and anti-cancer therapy. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28073157.","journal-title":"Molecules"},{"issue":"7","key":"1861_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2174\/1389450123666220111115528","volume":"23","author":"L Yang","year":"2022","unstructured":"Yang L, et al. Targeting mTOR signaling in type 2 diabetes mellitus and diabetes complications. Curr Drug Targets. 2022;23(7):692\u2013710.","journal-title":"Curr Drug Targets"},{"key":"1861_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nu14235171","author":"Y Cao","year":"2022","unstructured":"Cao Y, et al. Targeting mTOR signaling by dietary polyphenols in obesity prevention. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14235171.","journal-title":"Nutrients"},{"issue":"5","key":"1861_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tcm.2012.04.005","volume":"21","author":"ZZ Chong","year":"2011","unstructured":"Chong ZZ, Shang YC, Maiese K. Cardiovascular disease and mTOR signaling. Trends Cardiovasc Med. 2011;21(5):151\u20135.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"1861_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","volume":"16","author":"H Querfurth","year":"2021","unstructured":"Querfurth H, Lee HK. Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. 2021;16(1):44.","journal-title":"Mol Neurodegener"},{"issue":"17","key":"1861_CR25","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and tau. J Biol Chem. 2010;285(17):13107\u201320.","journal-title":"J Biol Chem"},{"issue":"8","key":"1861_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983\u201397.","journal-title":"Nat Med"},{"issue":"3","key":"1861_CR27","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease. Plos One. 2010;5(3):e9979.","journal-title":"Plos One"},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","volume":"10","author":"M Bordi","year":"2019","unstructured":"Bordi M, et al. mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy. Cell Death Dis. 2019;10:563.","journal-title":"Cell Death Dis"},{"key":"1861_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","volume":"84","author":"M Perluigi","year":"2015","unstructured":"Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015;84:39\u201349.","journal-title":"Neurobiol Dis"},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","volume":"341","author":"K Switon","year":"2017","unstructured":"Switon K, et al. Molecular neurobiology of mTOR. Neuroscience. 2017;341:112\u201353.","journal-title":"Neuroscience"},{"issue":"1","key":"1861_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, et al. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10(1):79\u2013104.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1861_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","volume":"161","author":"CU Correll","year":"2004","unstructured":"Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004;161(3):414\u201325.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1861_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00002512-200118010-00004","volume":"18","author":"MJ Byerly","year":"2001","unstructured":"Byerly MJ, et al. Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs Aging. 2001;18(1):45\u201361.","journal-title":"Drugs Aging"},{"issue":"5","key":"1861_CR34","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1073\/pnas.88.5.1948","volume":"88","author":"J Heitman","year":"1991","unstructured":"Heitman J, et al. FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1991;88(5):1948\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1861_CR35","first-page":"1718","volume":"11","author":"Y Koltin","year":"1991","unstructured":"Koltin Y, et al. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol Cell Biol. 1991;11(3):1718\u201323.","journal-title":"Mol Cell Biol"},{"key":"1861_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2202-11-22","volume":"11","author":"L Rivard","year":"2010","unstructured":"Rivard L, et al. A comparison of experience-dependent locomotory behaviors and biogenic amine neurons in nematode relatives of Caenorhabditis elegans. BMC Neurosci. 2010;11:22.","journal-title":"BMC Neurosci"},{"issue":"12","key":"1861_CR37","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82(12):4245\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1861_CR38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/002215540004800906","volume":"48","author":"SD Styren","year":"2000","unstructured":"Styren SD, et al. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer\u2019s disease pathology. J Histochem Cytochem. 2000;48(9):1223\u201332.","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"1861_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","volume":"43","author":"R Selvarani","year":"2021","unstructured":"Selvarani R, Mohammed S, Richardson A. Effect of rapamycin on aging and age-related diseases-past and future. Geroscience. 2021;43(3):1135\u201358.","journal-title":"Geroscience"},{"issue":"6","key":"1861_CR40","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12140","volume":"12","author":"K Seo","year":"2013","unstructured":"Seo K, et al. Heat shock factor 1 mediates the longevity conferred by inhibition of TOR and insulin\/IGF-1 signaling pathways in C. elegans. Aging Cell. 2013;12(6):1073\u201381.","journal-title":"Aging Cell"},{"issue":"5","key":"1861_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cub.2019.01.029","volume":"29","author":"J Xie","year":"2019","unstructured":"Xie J, et al. Regulation of the elongation phase of protein synthesis enhances translation accuracy and modulates lifespan. Curr Biol. 2019;29(5):737-749 e5.","journal-title":"Curr Biol"},{"issue":"10","key":"1861_CR42","doi-asserted-by":"publisher","first-page":"13474","DOI":"10.18632\/aging.203068","volume":"13","author":"HH Peng","year":"2021","unstructured":"Peng HH, et al. Ganoderma lucidum stimulates autophagy-dependent longevity pathways in Caenorhabditis elegans and human cells. Aging (Albany NY). 2021;13(10):13474\u201395.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"1861_CR43","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin C, et al. The hallmarks of aging. Cell. 2013;153(6):1194\u2013217.","journal-title":"Cell"},{"issue":"1\u20133","key":"1861_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2010.08.045","volume":"648","author":"G Sudeshna","year":"2010","unstructured":"Sudeshna G, Parimal K. Multiple non-psychiatric effects of phenothiazines: a review. Eur J Pharmacol. 2010;648(1\u20133):6\u201314.","journal-title":"Eur J Pharmacol"},{"key":"1861_CR45","doi-asserted-by":"publisher","first-page":"1320621","DOI":"10.3389\/fonc.2023.1320621","volume":"13","author":"SF Mehrabi","year":"2023","unstructured":"Mehrabi SF, Elmi S, Nylandsted J. Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells. Front Oncol. 2023;13:1320621.","journal-title":"Front Oncol"},{"key":"1861_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101360","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N. Antipsychotic drug fluphenazine against human cancer cells. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101360.","journal-title":"Biomolecules"},{"key":"1861_CR47","doi-asserted-by":"publisher","first-page":"116075","DOI":"10.1016\/j.bcp.2024.116075","volume":"222","author":"RM Lopes","year":"2024","unstructured":"Lopes RM, et al. Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy. Biochem Pharmacol. 2024;222:116075.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1861_CR48","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/acschemneuro.6b00380","volume":"8","author":"P Dao","year":"2017","unstructured":"Dao P, et al. Development of phenothiazine-based theranostic compounds that act both as inhibitors of beta-amyloid aggregation and as imaging probes for amyloid plaques in Alzheimer\u2019s disease. ACS Chem Neurosci. 2017;8(4):798\u2013806.","journal-title":"ACS Chem Neurosci"},{"key":"1861_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","volume":"11","author":"X Pan","year":"2019","unstructured":"Pan X, et al. Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network meta-analysis. Front Aging Neurosci. 2019;11:175.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1861_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1134\/S1990519X22030075","volume":"16","author":"LS Milenina","year":"2022","unstructured":"Milenina LS, et al. Sigma-1 receptor ligands chlorpromazine and trifluoperazine attenuate Ca(2+) responses in rat peritoneal macrophages. Cell Tissue Biol. 2022;16(3):233\u201344.","journal-title":"Cell Tissue Biol"},{"issue":"1","key":"1861_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","volume":"127","author":"L Nguyen","year":"2015","unstructured":"Nguyen L, et al. Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci. 2015;127(1):17\u201329.","journal-title":"J Pharmacol Sci"},{"key":"1861_CR52","unstructured":"Siragusa S, Bistas KG, Saadabadi A. Fluphenazine. In: StatPearls. 2025: Treasure Island (FL) ineligible companies. Disclosure: Karlyle Bistas declares no relevant financial relationships with ineligible companies. Disclosure: Abdolreza Saadabadi declares no relevant financial relationships with ineligible companies. 2025."},{"issue":"6","key":"1861_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1474-9726.2006.00238.x","volume":"5","author":"TL Kaeberlein","year":"2006","unstructured":"Kaeberlein TL, et al. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell. 2006;5(6):487\u201394.","journal-title":"Aging Cell"},{"key":"1861_CR54","doi-asserted-by":"publisher","unstructured":"Sutphin GL, Kaeberlein M. Measuring Caenorhabditis elegans life span on solid media. J Vis Exp. 2009(27). https:\/\/doi.org\/10.3791\/1152.","DOI":"10.3791\/1152"},{"issue":"1","key":"1861_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71\u201394.","journal-title":"Genetics"},{"key":"1861_CR56","doi-asserted-by":"publisher","unstructured":"Murakami C, Kaeberlein M. Quantifying yeast chronological life span by outgrowth of aged cells. J Vis Exp. 2009(27). https:\/\/doi.org\/10.3791\/1156.","DOI":"10.3791\/1156"},{"key":"1861_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2105-11-141","volume":"11","author":"B Olsen","year":"2010","unstructured":"Olsen B, Murakami CJ, Kaeberlein M. YODA: software to facilitate high-throughput analysis of chronological life span, growth rate, and survival in budding yeast. BMC Bioinformatics. 2010;11:141.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1861_CR58","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s11357-021-00418-x","volume":"43","author":"MB Lee","year":"2021","unstructured":"Lee MB, et al. Pterocarpus marsupium extract extends replicative lifespan in budding yeast. Geroscience. 2021;43(5):2595\u2013609.","journal-title":"Geroscience"},{"issue":"3","key":"1861_CR59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1474-9726.2008.00385.x","volume":"7","author":"KA Steinkraus","year":"2008","unstructured":"Steinkraus KA, et al. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell. 2008;7(3):394\u2013404.","journal-title":"Aging Cell"},{"issue":"6","key":"1861_CR60","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11357-019-00124-9","volume":"41","author":"JN Pitt","year":"2019","unstructured":"Pitt JN, et al. Wormbot, an open-source robotics platform for survival and behavior analysis in C. elegans. Geroscience. 2019;41(6):961\u201373.","journal-title":"Geroscience"},{"issue":"1","key":"1861_CR61","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017;18(1):529.","journal-title":"BMC Bioinform"},{"issue":"5","key":"1861_CR62","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s11357-021-00436-9","volume":"43","author":"JC Russell","year":"2021","unstructured":"Russell JC, et al. Generation and characterization of a tractable C. elegans model of tauopathy. Geroscience. 2021;43(5):2621\u201331.","journal-title":"Geroscience"},{"issue":"13","key":"1861_CR63","doi-asserted-by":"publisher","first-page":"109753","DOI":"10.1016\/j.celrep.2021.109753","volume":"36","author":"AB Lam","year":"2021","unstructured":"Lam AB, Kervin K, Tanis JE. Vitamin B(12) impacts amyloid beta-induced proteotoxicity by regulating the methionine\/S-adenosylmethionine cycle. Cell Rep. 2021;36(13):109753.","journal-title":"Cell Rep"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:02:00Z","timestamp":1783771320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01861-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.24.650484","asserted-by":"object"}]},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This article is published under an open access license. Please check the \u201cCopyright Information\u201d section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the license and re-use information, please contact the Rights and Permissions team.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Rights and permissions"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}